These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23336096)

  • 21. Biocompatibility and effectiveness of paclitaxel-encapsulated micelle using phosphoester compounds as a carrier for cancer treatment.
    Takeuchi I; Makino K
    Colloids Surf B Biointerfaces; 2019 May; 177():356-361. PubMed ID: 30772670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micelles.
    Wang F; Chen Y; Zhang D; Zhang Q; Zheng D; Hao L; Liu Y; Duan C; Jia L; Liu G
    Int J Nanomedicine; 2012; 7():325-37. PubMed ID: 22287842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.
    Xiao K; Luo J; Fowler WL; Li Y; Lee JS; Xing L; Cheng RH; Wang L; Lam KS
    Biomaterials; 2009 Oct; 30(30):6006-16. PubMed ID: 19660809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tumor activity of folate targeted biodegradable polymer-paclitaxel conjugate micelles on EMT-6 breast cancer model.
    Wu D; Zheng Y; Hu X; Fan Z; Jing X
    Mater Sci Eng C Mater Biol Appl; 2015 Aug; 53():68-75. PubMed ID: 26042692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptors.
    Zheng N; Dai W; Du W; Zhang H; Lei L; Zhang H; Wang X; Wang J; Zhang X; Gao J; Zhang Q
    Mol Pharm; 2012 May; 9(5):1175-88. PubMed ID: 22435704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
    Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
    Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery.
    Dagar S; Sekosan M; Lee BS; Rubinstein I; Onyüksel H
    J Control Release; 2001 Jul; 74(1-3):129-34. PubMed ID: 11489489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel mixed polymeric micelle for co-delivery of paclitaxel and retinoic acid and overcoming multidrug resistance: synthesis, characterization, cytotoxicity, and pharmacokinetic evaluation.
    Emami J; Rezazadeh M; Mashayekhi M; Rostami M; Jahanian-Najafabadi A
    Drug Dev Ind Pharm; 2018 May; 44(5):729-740. PubMed ID: 29235901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
    Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
    Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
    Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
    Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo.
    Wang N; Wang Z; Nie S; Song L; He T; Yang S; Yang X; Yi C; Wu Q; Gong C
    Int J Nanomedicine; 2017; 12():1499-1514. PubMed ID: 28260895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis.
    Koo OM; Rubinstein I; Onyüksel H
    Pharm Res; 2011 Apr; 28(4):776-87. PubMed ID: 21132352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
    Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy.
    Xiao Y; Wang S; Zong Q; Yin Z
    AAPS PharmSciTech; 2018 Jul; 19(5):2395-2406. PubMed ID: 29869309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of α-conotoxin ImI to actualize the targeted delivery of paclitaxel micelles to α7 nAChR-overexpressing breast cancer.
    Mei D; Lin Z; Fu J; He B; Gao W; Ma L; Dai W; Zhang H; Wang X; Wang J; Zhang X; Lu W; Zhou D; Zhang Q
    Biomaterials; 2015 Feb; 42():52-65. PubMed ID: 25542793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy.
    Banerjee I; De K; Mukherjee D; Dey G; Chattopadhyay S; Mukherjee M; Mandal M; Bandyopadhyay AK; Gupta A; Ganguly S; Misra M
    Acta Biomater; 2016 Jul; 38():69-81. PubMed ID: 27109765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis.
    Sethi V; Rubinstein I; Kuzmis A; Kastrissios H; Artwohl J; Onyuksel H
    Mol Pharm; 2013 Feb; 10(2):728-38. PubMed ID: 23211088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.